Nearly half of deaths in people with intellectual disability may be avoidable

The phrase "avoidable mortality" is a piece of public-health shorthand with teeth. It counts deaths that either should not have happened with good prevention, or should not have been fatal with timely treatment — and it is used to judge how well a health system serves a population, not how sick that population is. A systematic review published on 5 October applies that yardstick to people with intellectual and developmental disabilities, and the result is stark [s1].

Pooling 12 studies that together described 15 separate cohorts, the authors found that 45% of deaths in this group were classed as avoidable (95% CI 45–46), 22% as treatable (21–22) and 21% as preventable (20–21) [s1]. Compared with people without disabilities, that worked out to 3.60 times the rate of avoidable mortality (95% CI 3.53–3.68), 5.82 times the treatable mortality (5.64–6.01) and 2.58 times the preventable mortality (2.50–2.66) [s1].

The treatable gap is the loudest signal

Of the three sub-measures, the treatable figure is the one that should trouble clinicians most. Preventable deaths turn largely on upstream factors — housing, smoking, air quality, the slow accumulation of risk — where a health service is one actor among many. Treatable mortality is different: it measures deaths from conditions that medicine already knows how to manage, where the patient reached the point of dying from something a hospital could have fixed. A rate nearly six times higher in people with intellectual disability points not at biology but at the clinical encounter itself — at diagnoses missed because symptoms were attributed to the disability, at care not adjusted for communication needs, at the long-documented problem of reasonable adjustments that never arrive.

The authors are careful about how far the numbers reach. Some of the excess, they note, may stem from the underlying impairments themselves rather than from any failure of care [s1]. But a gap this large, concentrated in the treatable column, is unlikely to be explained by impairment alone — which is the review's central claim, and the reason it reads as a health-systems indictment rather than a statement about disease [s1].

The distinction is not academic. If most of the excess were impairment-driven, the policy response would be palliative — better support for an unavoidably shorter life. Because so much of it sits in the treatable category, the response the evidence points to is operational: closing the gap means changing how clinics detect and manage ordinary illness in patients who may not present or communicate in the expected way. Those are fixable process failures, and framing them as such is what turns a mortality statistic into an accountability measure.

A high-income picture, and its blind spot

The screening process began with 1,250 deduplicated records and ended with a small, consistent evidence base [s1]. Three-quarters of the included cohorts were judged at low risk of bias and the rest at medium, on a standard appraisal tool, so the pooled estimate is not being dragged by weak studies [s1]. The protocol was registered in advance on PROSPERO, which constrains the kind of after-the-fact analytic choices that can inflate a finding [s2].

The sharper limitation is where the data come from. Every included cohort was from a high-income country, and every one examined intellectual or developmental disability specifically [s1]. That leaves two large silences. The first is the rest of the world: an estimated 1.3 billion people — about 16% of the global population — live with significant disability, the overwhelming majority in low- and middle-income countries where health systems are thinner and the avoidable-mortality gap is, if anything, likely to be wider [s3]. The second is the rest of the disability spectrum. Physical and sensory disabilities, which carry their own access barriers, simply were not captured by the available studies, so this is a finding about one group standing in for many.

Why it belongs on the breaking desk

Avoidable-mortality statistics rarely make news because they describe a steady state rather than an event. But the mechanism here is portable in exactly the way an outbreak is not: nothing in the finding is specific to one country's system, and the treatable-mortality gap is a measurable, auditable target that any health service can test against its own records. The review's closing argument is that these deaths are a signal to act on — that health systems must adapt their accessibility and the quality of care they deliver to this population, rather than treating a shorter life expectancy as an inevitable feature of disability [s1]. The number to watch is not the 45%; it is whether the treatable gap narrows when systems are measured against it.

Sources

• Avoidable mortality for people with disabilities: a systematic review and meta-analysis — BMJ Public Health, 5 October 2026
• PROSPERO registration CRD420251072430 — PROSPERO, University of York
• Disability and health (fact sheet) — World Health Organization